RenovoRx RNXT
NASDAQ RNXT
$1.56 -0.01 (-0.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Net Margin (2025 - 2026)

Updated

RenovoRx (RNXT) recorded Net Margin of -368.43% in Q2 2026, up 317.59 percentage points from -686.02% a year earlier and up 247.74 percentage points from the prior quarter.

Analysis

RenovoRx (RNXT) Net Margin (2025 - 2026) Analysis & Trends

On a TTM basis, RenovoRx's Net Margin came in at -670.65% as of Jun 30, 2026; for FY2025, it came in at -1113.98%, up 24397.65 percentage points from FY2024.

  • Across earlier years, Net Margin came in at -25511.63% in FY2024.
  • Per Business Quant, the preceding three quarters came in at -616.16% (Q1 2026), -1479.83% (Q4 2025) and -1094.74% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 14.47%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 7.37%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 13.89%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 28.29%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 15.07%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 19.37%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 16.67%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 13.89%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 7.57%
10 RenovoRx 70.84 Mn 70.84 Mn 766,000.00 -368.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -368.43%
Mar 31, 2026 -616.16%
Dec 31, 2025 -1,479.83%
Sep 30, 2025 -1,094.74%
Jun 30, 2025 -686.02%
Mar 31, 2025 -1,228.43%
API Access

RenovoRx Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=RNXT&period=max&api_key=YOUR_API_KEY